Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
0yT3jRKfba1mYcpC
